学术探索
学术期刊
新闻热点
数据分析
智能评审

Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences

被引：1797
作者：
Ganem, D
Prince, AM
机构：
[1] New York Blood Ctr, Lindsley F Kimball Res Inst, Virol Lab, New York, NY 10021 USA
[2] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
[5] NYU, Sch Med, Dept Pathol, New York, NY USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 11期
关键词：
D O I：
10.1056/NEJMra031087
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1118 / 1129
页数：12
相关论文
共 82 条
  • [41] Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    Marcellin, P
    Chang, T
    Lim, SG
    Tong, MJ
    Sievert, W
    Shiffman, ML
    Jeffers, L
    Goodman, Z
    Wulfsohn, MS
    Xiong, S
    Fry, J
    Brosgart, CL
    Afdhal, N
    O'Conner, C
    Andreone, P
    Cursaro, C
    Angus, P
    Vaughan, R
    Bain, V
    Gutfreund, K
    Barange, K
    Duffant, M
    Barnes, E
    Bennett, M
    Pressman, J
    Bernstein, D
    Bonino, F
    Coco, B
    Borum, M
    Schuck, S
    Bourliere, M
    Benali, S
    Boyer, N
    Castelnau, C
    Brown, R
    Scales, S
    Buggisch, P
    Peterson, J
    Cooksley, G
    MacDonald, G
    Couzigou, P
    Foucner, D
    Crawford, D
    Der, A
    Desmond, P
    Boussioutas, A
    DiBisceglie, A
    Bacon, B
    Dieterich, D
    Goldman, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) : 808 - 816
  • [42] MARION PL, 1988, PROG MED VIROL, V35, P43
  • [43] MATSUBARA K, 1990, MOL BIOL MED, V7, P243
  • [44] Hepatitis B virus mutants associated with 3TC and Famciclovir administration are replication defective
    Melegari, M
    Scaglioni, PP
    Wands, JR
    [J]. HEPATOLOGY, 1998, 27 (02) : 628 - 633
  • [45] An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals
    Nelson, M
    Portsmouth, S
    Stebbing, J
    Atkins, M
    Barr, A
    Matthews, G
    Pillay, D
    Fisher, M
    Bower, M
    Gazzard, B
    [J]. AIDS, 2003, 17 (01) : F7 - F10
  • [46] Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
    Niederau, C
    Heintges, T
    Lange, S
    Goldmann, G
    Niederau, CM
    Mohr, L
    Haussinger, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (22) : 1422 - 1427
  • [47] HEPATITIS B-VIRUSES WITH PRECORE REGION DEFECTS PREVAIL IN PERSISTENTLY INFECTED HOSTS ALONG WITH SEROCONVERSION TO THE ANTIBODY AGAINST E-ANTIGEN
    OKAMOTO, H
    YOTSUMOTO, S
    AKAHANE, Y
    YAMANAKA, T
    MIYAZAKI, Y
    SUGAI, Y
    TSUDA, F
    TANAKA, T
    MIYAKAWA, Y
    MAYUMI, M
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (03) : 1298 - 1303
  • [48] Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
    Perrillo, R
    Rakela, J
    Dienstag, J
    Levy, G
    Martin, P
    Wright, T
    Caldwell, S
    Schiff, E
    Gish, R
    Villeneuve, JP
    Farr, G
    Anschuetz, G
    Crowther, L
    Brown, N
    [J]. HEPATOLOGY, 1999, 29 (05) : 1581 - 1586
  • [49] Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
    Perrillo, R
    Schiff, E
    Yoshida, E
    Statler, A
    Hirsch, K
    Wright, T
    Gutfreund, K
    Lamy, P
    Murray, A
    [J]. HEPATOLOGY, 2000, 32 (01) : 129 - 134
  • [50] SITE-SPECIFIC RNA-BINDING BY A HEPATITIS-B VIRUS REVERSE-TRANSCRIPTASE INITIATES 2 DISTINCT REACTIONS - RNA PACKAGING AND DNA-SYNTHESIS
    POLLACK, JR
    GANEM, D
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 5579 - 5587
123456789